B-Disease	0	8	Dominant
I-Disease	9	16	cystoid
I-Disease	17	24	macular
I-Disease	25	34	dystrophy
O	34	35	.

O	37	39	To
O	40	48	describe
O	49	52	the
O	53	61	clinical
O	62	77	characteristics
O	78	81	and
O	82	86	long
O	86	87	-
O	87	91	term
O	92	98	follow
O	98	99	-
O	99	101	up
O	102	104	in
O	105	113	patients
O	114	118	with
B-Disease	119	128	autosomal
I-Disease	129	137	dominant
I-Disease	138	145	cystoid
I-Disease	146	153	macular
I-Disease	154	163	dystrophy
O	164	165	(
B-Disease	165	169	DCMD
O	169	170	)
O	170	171	.

O	172	185	Retrospective
O	186	190	case
O	191	197	series
O	197	198	.

O	199	205	Ninety
O	205	206	-
O	206	211	seven
O	212	220	patients
O	221	225	with
B-Disease	226	230	DCMD
O	230	231	.

O	232	241	Extensive
O	242	252	ophthalmic
O	253	264	examination
O	264	265	,
O	266	275	including
B-Characteristic	276	282	visual
I-Characteristic	283	289	acuity
O	290	291	(
B-Characteristic	291	293	VA
O	293	294	)
O	294	295	,
B-Diagnostic_tool	296	302	fundus
I-Diagnostic_tool	303	314	photography
O	314	315	,
B-Diagnostic_tool	316	327	fluorescein
I-Diagnostic_tool	328	339	angiography
O	340	341	(
B-Diagnostic_tool	341	343	FA
O	343	344	)
O	344	345	,
B-Diagnostic_tool	346	352	fundus
I-Diagnostic_tool	353	369	autofluorescence
I-Diagnostic_tool	370	371	(
I-Diagnostic_tool	371	374	FAF
I-Diagnostic_tool	374	375	)
I-Diagnostic_tool	376	383	imaging
O	383	384	,
B-Diagnostic_tool	385	392	optical
I-Diagnostic_tool	393	402	coherence
I-Diagnostic_tool	403	413	tomography
O	414	415	(
B-Diagnostic_tool	415	418	OCT
O	418	419	)
O	419	420	,
B-Diagnostic_tool	421	426	color
I-Diagnostic_tool	427	433	vision
I-Diagnostic_tool	434	441	testing
O	441	442	,
B-Diagnostic_tool	443	447	dark
I-Diagnostic_tool	448	458	adaptation
I-Diagnostic_tool	459	466	testing
O	466	467	,
B-Diagnostic_tool	468	472	full
I-Diagnostic_tool	472	473	-
I-Diagnostic_tool	473	478	field
I-Diagnostic_tool	479	498	electroretinography
O	499	500	(
B-Diagnostic_tool	500	503	ERG
O	503	504	)
O	504	505	,
O	506	509	and
B-Diagnostic_tool	510	517	electro
I-Diagnostic_tool	517	518	-
I-Diagnostic_tool	518	529	oculography
O	530	531	(
B-Diagnostic_tool	531	534	EOG
O	534	535	)
O	535	536	.

O	537	542	Blood
O	543	550	samples
O	551	555	were
O	556	564	obtained
O	565	568	for
O	569	572	DNA
O	573	583	extraction
O	584	587	and
O	588	598	subsequent
B-Diagnostic_tool	599	608	haplotype
I-Diagnostic_tool	609	617	analysis
O	617	618	.

B-Characteristic	619	622	Age
I-Characteristic	623	625	at
I-Characteristic	626	631	onset
O	631	632	,
B-Characteristic	633	635	VA
O	635	636	,
B-Characteristic	637	643	fundus
I-Characteristic	644	654	appearance
O	654	655	,
O	656	659	and
O	660	675	characteristics
O	676	678	on
B-Diagnostic_tool	679	681	FA
O	681	682	,
B-Diagnostic_tool	683	686	FAF
O	686	687	,
B-Diagnostic_tool	688	691	OCT
O	691	692	,
B-Diagnostic_tool	693	696	ERG
O	696	697	,
O	698	701	and
B-Diagnostic_tool	702	705	EOG
O	705	706	.

B-Symptom	707	714	Cystoid
I-Symptom	715	720	fluid
I-Symptom	721	732	collections
O	733	734	(
B-Symptom	734	738	CFCs
O	738	739	)
O	740	744	were
O	745	748	the
O	749	754	first
B-Symptom	755	762	retinal
I-Symptom	763	776	abnormalities
O	777	787	detectable
O	788	790	in
B-Disease	791	795	DCMD
O	795	796	,
O	797	807	developing
O	808	814	during
B-Characteristic	815	824	childhood
O	824	825	.

O	826	828	At
O	829	833	long
O	833	834	-
O	834	838	term
O	839	845	follow
O	845	846	-
O	846	848	up
O	848	849	,
O	850	853	the
B-Symptom	854	858	CFCs
O	859	868	decreased
O	869	871	in
O	872	876	size
O	877	880	and
O	881	887	number
O	887	888	,
O	889	892	and
O	893	903	eventually
O	904	915	disappeared
O	916	920	with
O	921	931	concurrent
O	932	943	development
O	944	946	of
B-Symptom	947	958	progressive
I-Symptom	959	972	chorioretinal
I-Symptom	973	980	atrophy
O	981	984	and
B-Symptom	985	999	hyperpigmented
I-Symptom	1000	1008	deposits
I-Symptom	1009	1011	in
I-Symptom	1012	1015	the
I-Symptom	1016	1025	posterior
I-Symptom	1026	1030	pole
O	1030	1031	.

B-Disease	1032	1040	Dominant
I-Disease	1041	1048	cystoid
I-Disease	1049	1056	macular
I-Disease	1057	1066	dystrophy
O	1067	1072	could
O	1073	1075	be
O	1076	1086	classified
O	1087	1091	into
O	1092	1093	3
O	1094	1100	stages
O	1100	1101	,
O	1102	1107	based
O	1108	1110	on
O	1111	1126	characteristics
O	1127	1129	on
B-Diagnostic_tool	1130	1144	ophthalmoscopy
O	1144	1145	,
B-Diagnostic_tool	1146	1149	FAF
O	1149	1150	,
B-Diagnostic_tool	1151	1153	FA
O	1153	1154	,
O	1155	1158	and
B-Diagnostic_tool	1159	1162	OCT
O	1162	1163	,
O	1164	1166	as
O	1167	1171	well
O	1172	1174	as
O	1175	1177	on
O	1178	1185	results
O	1186	1188	of
B-Diagnostic_tool	1189	1207	electrophysiologic
I-Diagnostic_tool	1208	1216	analysis
O	1216	1217	.

O	1218	1221	The
O	1222	1229	staging
O	1230	1236	system
O	1237	1247	correlated
O	1248	1252	with
B-Characteristic	1253	1256	age
O	1257	1260	and
B-Characteristic	1261	1263	VA
O	1263	1264	.

O	1265	1267	In
B-Disease	1268	1273	stage
I-Disease	1274	1275	1
I-Disease	1276	1280	DCMD
O	1281	1282	(
O	1282	1284	20
O	1285	1293	patients
O	1293	1294	;
O	1295	1297	22
O	1297	1298	%
O	1298	1299	)
O	1299	1300	,
O	1301	1309	patients
O	1310	1319	generally
O	1320	1324	were
B-Characteristic	1325	1332	younger
I-Characteristic	1333	1337	than
I-Characteristic	1338	1340	20
I-Characteristic	1341	1346	years
O	1347	1350	and
O	1351	1354	had
B-Symptom	1355	1359	CFCs
I-Symptom	1360	1364	with
I-Symptom	1365	1369	fine
I-Symptom	1370	1377	folding
I-Symptom	1378	1380	of
I-Symptom	1381	1384	the
I-Symptom	1385	1393	internal
I-Symptom	1394	1402	limiting
I-Symptom	1403	1411	membrane
O	1412	1415	and
B-Symptom	1416	1420	mild
I-Symptom	1421	1428	pigment
I-Symptom	1429	1436	changes
O	1436	1437	.

O	1438	1440	In
B-Disease	1441	1446	stage
I-Disease	1447	1448	2
I-Disease	1449	1453	DCMD
O	1454	1455	(
O	1455	1457	48
O	1458	1466	patients
O	1466	1467	;
O	1468	1470	52
O	1470	1471	%
O	1471	1472	)
O	1472	1473	,
O	1474	1477	the
B-Symptom	1478	1482	CFCs
O	1483	1489	tended
O	1490	1492	to
O	1493	1501	decrease
O	1502	1504	in
O	1505	1509	size
O	1509	1510	,
O	1511	1514	and
B-Symptom	1515	1523	moderate
I-Symptom	1524	1531	macular
I-Symptom	1532	1545	chorioretinal
I-Symptom	1546	1553	atrophy
O	1554	1563	developed
O	1563	1564	.

O	1565	1573	Patients
O	1574	1578	with
B-Disease	1579	1584	stage
I-Disease	1585	1586	3
I-Disease	1587	1591	DCMD
O	1592	1593	(
O	1593	1595	24
O	1596	1604	patients
O	1604	1605	;
O	1606	1608	26
O	1608	1609	%
O	1609	1610	)
O	1611	1620	generally
O	1621	1625	were
B-Characteristic	1626	1631	older
I-Characteristic	1632	1636	than
I-Characteristic	1637	1639	50
I-Characteristic	1640	1645	years
O	1646	1649	and
O	1650	1656	showed
B-Symptom	1657	1665	profound
I-Symptom	1666	1679	chorioretinal
I-Symptom	1680	1687	atrophy
O	1687	1688	,
O	1689	1691	as
O	1692	1696	well
O	1697	1699	as
B-Symptom	1700	1706	coarse
I-Symptom	1707	1721	hyperpigmented
I-Symptom	1722	1730	deposits
I-Symptom	1731	1733	in
I-Symptom	1734	1737	the
I-Symptom	1738	1747	posterior
I-Symptom	1748	1752	pole
O	1752	1753	.

O	1754	1758	Most
O	1759	1767	patients
O	1768	1772	were
O	1773	1774	(
O	1774	1780	highly
O	1780	1781	)
B-Symptom	1782	1791	hyperopic
O	1792	1793	(
O	1793	1795	72
O	1796	1804	patients
O	1804	1805	;
O	1806	1808	92
O	1808	1809	%
O	1809	1810	)
O	1810	1811	.

O	1812	1815	All
B-Disease	1816	1820	DCMD
O	1821	1829	patients
O	1830	1836	shared
O	1837	1840	the
O	1841	1848	disease
B-Characteristic	1849	1858	haplotype
I-Characteristic	1859	1861	at
I-Characteristic	1862	1865	the
I-Characteristic	1866	1870	DCMD
I-Characteristic	1871	1876	locus
I-Characteristic	1877	1879	at
I-Characteristic	1880	1884	7p15
I-Characteristic	1884	1885	.
I-Characteristic	1885	1886	3
O	1886	1887	.

B-Disease	1888	1896	Dominant
I-Disease	1897	1904	cystoid
I-Disease	1905	1912	macular
I-Disease	1913	1922	dystrophy
O	1923	1925	is
O	1926	1927	a
B-Disease	1928	1939	progressive
I-Disease	1940	1947	retinal
I-Disease	1948	1957	dystrophy
O	1957	1958	,
O	1959	1972	characterized
O	1973	1982	primarily
O	1983	1985	by
B-Symptom	1986	1991	early
I-Symptom	1991	1992	-
I-Symptom	1992	1997	onset
I-Symptom	1998	2005	cystoid
I-Symptom	2006	2011	fluid
I-Symptom	2012	2023	collections
I-Symptom	2024	2026	in
I-Symptom	2027	2030	the
I-Symptom	2031	2042	neuroretina
O	2042	2043	,
O	2044	2049	which
O	2050	2063	distinguishes
O	2064	2068	this
O	2069	2077	disorder
O	2078	2082	from
O	2083	2088	other
B-Disease	2089	2096	retinal
I-Disease	2097	2108	dystrophies
O	2108	2109	.

O	2110	2113	The
O	2114	2124	phenotypic
O	2125	2130	range
O	2131	2133	of
B-Disease	2134	2138	DCMD
O	2139	2142	can
O	2143	2145	be
O	2146	2156	classified
O	2157	2161	into
O	2162	2163	3
O	2164	2170	stages
O	2170	2171	.

O	2172	2175	The
O	2176	2183	genetic
O	2184	2189	locus
O	2190	2193	for
O	2194	2198	this
B-Disease	2199	2206	retinal
I-Disease	2207	2216	dystrophy
O	2217	2220	has
O	2221	2225	been
O	2226	2232	mapped
O	2233	2235	to
O	2236	2240	7p15
O	2240	2241	.
O	2241	2242	3
O	2242	2243	,
O	2244	2247	but
O	2248	2251	the
O	2252	2260	involved
O	2261	2265	gene
O	2266	2268	is
O	2269	2278	currently
O	2279	2286	unknown
O	2286	2287	.
